P
Pasithea Therapeutics Corp. (KTTA)
NCM – Real Time Price. Currency in USD
0.54
+0.00 (0.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.54
-0.01 (-1.55%)
After-hours: Jun 26, 2026, 6:32 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.54
+0.00 (0.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.54
-0.01 (-1.55%)
After-hours: Jun 26, 2026, 6:32 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 35.40 | 6.05 | 10 | |
| Quick ratio | 35.40 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -5K | -648K | -649K | -663K | -659K |
| Operating Income | -13M | -16M | -14M | -17M | -22M |
| Net Income | -14M | -16M | -14M | -20M | -20M |
| EBITDA | -13M | -15M | -14M | -16M | -21M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 75.76 | 5.5 |
| Next quarter | N/A | 48.78 | 5.5 |
| Current year | N/A | 73.88 | 5.5 |
| Next year | N/A | -32.89 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 71.62 | 84.81 | 11.3 | 9.3 |
| Y/Y | 999 | 19.47 | N/A | -56.65 | 5.3 |
| 3y average | 999 | -16.17 | N/A | -3.4 | 3.3 |
| 5y average | 779.2 | -1158.6 | N/A | -1700.27 | 3.3 |
| Weighted average score | 5.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $50.5M barely cover the upcoming debt maturities $0.0
Total current assets $52.7M exceed Total current liabilities $1.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.8M limits the company's ability to reinvest or pay down debt